Last reviewed · How we verify
Tofacitinib and Acitretin Capsules. — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Tofacitinib and Acitretin Capsules. (Tofacitinib and Acitretin Capsules.) — Army Medical University, China.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tofacitinib and Acitretin Capsules. TARGET | Tofacitinib and Acitretin Capsules. | Army Medical University, China | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tofacitinib and Acitretin Capsules. CI watch — RSS
- Tofacitinib and Acitretin Capsules. CI watch — Atom
- Tofacitinib and Acitretin Capsules. CI watch — JSON
- Tofacitinib and Acitretin Capsules. alone — RSS
Cite this brief
Drug Landscape (2026). Tofacitinib and Acitretin Capsules. — Competitive Intelligence Brief. https://druglandscape.com/ci/tofacitinib-and-acitretin-capsules. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab